Bio-Rad Buys GnuBI

(RTTNews) - Bio-Rad Laboratories, Inc. (BIO), a manufacturer of life science research and clinical diagnostic products, said Thursday that it has bought GnuBIO, Inc.

Based in Cambridge, Massachusetts, GnuBIO is developing a faster and fully integrated droplet-based DNA sequencing technology that incorporates all the functions of DNA sequencing into a single, integrated workflow for medical diagnostics as well as research markets.

While other sequencing technologies require separate workflows for target selection, DNA amplification, DNA sequencing and analysis, GnuBIO's technology will integrate the entire workflow into a single, low-cost solution that produces results within hours, versus days.